首页|期刊导航|检验医学与临床|尿毒症维持性血液透析患者CRI病原菌分布特征及CRI与血清MCP-1、G-CSF、HBD-3的关系

尿毒症维持性血液透析患者CRI病原菌分布特征及CRI与血清MCP-1、G-CSF、HBD-3的关系OA

Distribution characteristics of catheter-related infection pathogens and their relationship with serum MCP-1,G-CSF and HBD-3 in uremic patients undergoing maintenance hemodialysis

中文摘要英文摘要

目的 探讨尿毒症维持性血液透析(MHD)患者导管相关性感染(CRI)病原菌分布特征及CRI与血清单核细胞趋化蛋白-1(MCP-1)、粒细胞集落刺激因子(G-CSF)、人β-防御素-3(HBD-3)的关系.方法 选取2023年4月至2025年4月华中科技大学协和江北医院收治的168例尿毒症 MHD患者作为研究对象.根据导管留置期间或导管拔除后48 h内是否发生CRI将患者分为CRI组、无CRI组.检测发生CRI的尿毒症MHD患者病原菌分布情况.采用酶联免疫吸附试验检测所有患者 MCP-1、G-CSF、HBD-3水平.采用多因素Logistic回归分析影响尿毒症 MHD患者发生CRI的因素.采用受试者工作特征(ROC)曲线分析血清 MCP-1、G-CSF、HBD-3及3项联合对尿毒症 MHD患者发生 CRI的预测效能.结果 82例发生 CRI的尿毒症MHD患者共培养出病原菌86株,其中革兰阴性菌54株(62.79%),革兰阳性菌27株(31.40%),真菌5株(5.81%).CRI组血清 MCP-1、G-CSF水平高于无CRI组(P<0.05),HBD-3水平低于无CRI组(P<0.05).血清 MCP-1、G-CSF水平升高是尿毒症 MHD患者发生CRI的危险因素(P<0.05),HBD-3水平升高是尿毒症 MHD患者发生CRI的保护因素(P<0.05).血清 MCP-1、G-CSF、HBD-3预测尿毒症 MHD患者发生CRI的曲线下面积(AUC)分别为0.862、0.848、0.800,灵敏度分别为89.02%、87.80%、65.85%,特异度分别为66.28%、63.95%、77.91%;MCP-1、G-CSF、HBD-3联合预测尿毒症 MHD患者发生CRI的AUC为0.943,明显大于单项指标预测的 AUC(Z联合-MCP-1=2.621,P联合-MCP-1=0.009;Z联合-G-CSF=2.865,P联合-G-CSF=0.004;Z联合-HBD-3=4.172,P联合-HBD-3<0.001).结论 血清 MCP-1、G-CSF、HBD-3与尿毒症 MHD患者发生CRI密切相关,3项指标联合检测有助于临床预测尿毒症 MHD患者发生CRI.

Objective To investigate the distribution characteristics of catheter-related infection(CRI)pathogens and their relationship with serum monocyte chemoattractant protein-1(MCP-1),granulocyte colo-ny-stimulating factor(G-CSF),human β-defensin-3(HBD-3)and CRI in uremic patients undergoing mainte-nance hemodialysis(MHD).Methods A total of 168 uremic MHD patients admitted to Union Jiangbei Hos-pital,Huazhong University of Science and Technology from April 2023 to April 2025 were selected as the study subjects.The patients were divided into a CRI group and a non-CRI group according to whether CRI oc-curred during catheter indwelling or within 48 h after catheter removal.The distribution of pathogens in ure-mic MHD patients with CRI was analyzed.Serum levels of MCP-1,G-CSF and HBD-3 were measured in all patients by enzyme-linked immunosorbent assay.Multivariate Logistic regression analysis was performed to i-dentify the factors influencing the occurrence of CRI in uremic MHD patients.Receiver operating characteris-tic(ROC)curve was plotted to evaluate the predictive efficacy of serum MCP-1,G-CSF,HBD-3 and their combination for CRI occurrence in uremic MHD patients.Results A total of 86 pathogenic strains were isola-ted from 82 uremic MHD patients with CRI,including 54 strains of Gram-negative bacteria(62.79%),27 strains of Gram-positive bacteria(31.40%),and 5 strains of fungi(5.81%).Serum levels of MCP-1 and G-CSF in the CRI group were significantly higher than those in the non-CRI group(P<0.05),whereas the ser-um HBD-3 level in the CRI group was significantly lower than that in the non-CRI group(P<0.05).Elevated serum MCP-1 and G-CSF levels were identified as risk factors for CRI in uremic MHD patients(P<0.05),whereas elevated serum HBD-3 level was identified as a protective factor against CRI in uremic MHD patients(P<0.05).The areas under the curves(AUCs)of serum MCP-1,G-CSF and HBD-3 for predicting CRI in uremic MHD patients were 0.862,0.848 and 0.800 respectively,with sensitivities of 89.02%,87.80%and 65.85%,and specificities of 66.28%,63.95%and 77.91%respectively.The AUC of the combination of MCP-1,G-CSF and HBD-3 for predicting CRI in uremic MHD patients was 0.943,which was significantly greater than the AUC of any single index(Zcombination vs.MCP-1=2.621,Pcombination vs.MCP-1=0.009;Zcombination vs.G-CSF=2.865,Pcombination vs.G-CSF=0.004;Zcombination vs.HBD-3=4.172,Pcombination vs.HBD-3<0.001).Conclusion Serum MCP-1,G-CSF and HBD-3 are closely associated with the occurrence of CRI in uremic MHD patients.Combined detection of these three indicators may facilitate clinical prediction of CRI in uremic MHD patients.

汤娜;熊怡;刘娟;冯雪

华中科技大学协和江北医院肾内科,湖北 武汉 430100华中科技大学协和江北医院肾内科,湖北 武汉 430100华中科技大学协和江北医院肾内科,湖北 武汉 430100湖北省武汉市中医医院肾病科,湖北 武汉 430014

医药卫生

尿毒症维持性血液透析病原菌单核细胞趋化蛋白-1粒细胞集落刺激因子人β-防御素-3

uremiamaintenance hemodialysispathogensmonocyte chemoattractant protein-1granulocyte colony-stimulating factorhuman β-defensin-3

《检验医学与临床》 2026 (12)

1664-1670,7

湖北省武汉市卫生健康委员会基金项目(WX21D82).

10.3969/j.issn.1672-9455.2026.12.013

评论